Ber-EP4 for differentiating adenocarcinoma from reactive and neoplastic mesothelial cells in serous effusions: Comparison with carcinoembryonic antigen, B72.3 and Leu-M1

Acta Cytologica

Volumn 40, Issue 6, 1996, Pages 1212-1216

  Bailey, Michael E ^a   Brown, Richard W ^a   Mody, Dina R ^a   Cagle, Philip ^a   Ramzy, Ibrahim ^a,b  

^a HOUSTON METHODIST HOSPITAL   (United States)

^b Obstetrics and Gynecology   (United States)

Author keywords

Adenocarcinoma; Ber EP4; Immunohistochemistry; Mesothelioma

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CD15 ANTIGEN; TUMOR ANTIGEN;

ADENOCARCINOMA; ANTIGEN DETECTION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EFFUSION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MESOTHELIUM CELL; PRIORITY JOURNAL;

ZIZIPHUS MAURITIANA;

EID: 0030447172     PISSN: 00015547     EISSN: 19382650     Source Type: Journal    
DOI: 10.1159/000333982     Document Type: Article

References (22)

1. Croonen AM, van der Valk P, Herman W, Linderman J: Cytology, immunopathology, and flow cytometry in the diagnosis of pleural and peritoneal effusions. Lab Invest 1988;58:725-732
2. DeAngelis M, Buley ID, Heryet A, Gray W: Immunocyto-chemical staining of serous effusions with the monoclonal antibody Ber-EP4. Cytopathology 1992;3:111-117
3. Diaz-Arias AA, Loy TS, Bickel JT, Chapman RK: Utility of Ber-EP4 in the diagnosis of adenocarcinoma in effusions: An immunocytochemical study of 232 cases. Diagn Cytopathol 1993;9:516-521
4. Esteben JM, Yokota S, Husam S, Battifora H: Immunocyto-chemical profile of benign and carcinomatous effusions: A practical approach to difficult diagnosis. Am J Clin Pathol 1990;94:698-705
5. Flynn MK, Johnston W, Bigner S: Carcinoma of ovarian and other origin in effusions: Immunocytochemical study with a panel of monoclonal antibodies. Acta Cytol 1993;37:439-447
6. Frisman DM, McCarthy WF, Schleiff P, Buckner S-B, Nocito JD, O'Leary TJ: Immunocytochemistry in the differential diagnosis of effusions: Use of a logistic regression to select a panel of antibodies to distinguish adenocarcinomas from mesothelial proliferations. Mod Pathol 1993;6:179-181
7. Gaffey MJ, Mills SE, Swanson PE, Zarbo RJ, Shar AR, Wick MR: Immuno reactivity for Ber-EP4 in adenocarcinomas, adenomatoid tumors and malignant mesotheliomas. Am J Surg Pathol 1992;16:593-599
8. Guzman J, Bross KJ, Wurtemberger G, Costabel U: Immuno-cytology in malignant pleural mesothelioma: Expression of tumor markers and distribution of lymphocyte subsets. Chest 1989;95:590-595
9. Johnston WW, Szpak CA, Thor A, Simpson JF, Schlom J: Applications of immunocytochemistry to clinical cytology. Cancer Invest 1987;5:593-611
10. Kuhlmann L, Berghauser KH, Schaffer R: Distinction of mesothelioma from carcinoma in pleural effusions: An im-munocytochemical study on routinely processed cytoblock preparations. Pathol Res Pract 1991;187:467-471
11. Latza U, Niedobitek G, Schwarting R, Nekarda H, Stein H: Ber-EP4: New monoclonal antibody which distinguishes ep-ithelia from mesothelia. J Clin Pathol 1990;43:213-219
12. Marsella RC, Buckner SB, Bratthauer GL, O'Leary TJ: Identification of adenocarcinoma in effusions: A comparison of immunoperoxidase staining for monoclonal antibody B72.3 and carcinoembryonic antigen. Acta Cytol 1990;34:578-579
13. Mason MR, Bedrossian CWM, Fahey CA: Value of immuno-cytochemistry in the study of malignant effusions. Diagn Cy-topathol 1987;3:215-221
14. Nance KV, Silverman JF: Immunocytochemical panel for the identification of malignant cells in serous effusions. Am J Clin Pathol 1991;95:867-874
15. Sheibani K, Shin SS, Kezirian J, Weiss LM: Ber-EP4 antibody as a discriminant in the differential diagnosis of malignant mesothelioma versus adenocarcinoma. Am J Surg Pathol 1991;8:779-784
16. Shield PW, Callon JJ, Devine PL: Markers for metastatic adenocarcinoma in serous effusion specimens. Diagn Cyto-pathol 1994;11:237-245
17. Silverman JF, Nance K, Phillips B, Norris HT: The use of immunoperoxidase panels for the cytologic diagnosis of malignancy in serous effusions. Diagn Cytopathol 1987;3:134-140
18. Stoop JA, Hendricks JGM, Berends D: Identification of malignant cells in serous effusions using a panel of monoclonal antibodies: Ber-EP4, MC-6-12, and EMA. Cytopathology 1992;3:297-302
19. Szpak CA, Soper JT, Thor A, Schlom J, Johnston WW: Detection of adenocarcinoma in peritoneal washings by staining with monoclonal antibody B72.3. Acta Cytol 1989;33:205-214
20. Tickman RJ, Cohen C, Varma VA, Fekete PS, DeRose PB: Distinction between carcinoma cells and mesothelial cells in serous effusions: Usefulness of immunohistochemistry. Acta Cytol 1990;34:491-496
21. Warhol MJ, Hickey WF, Corson JM: Malignant mesotheliomas: Ultrastructural distinction from adenocarcinoma. Am J Surg Pathol 1982;6:307-314
22. Whitaker D, Sterrett GF, Shilkin KB: Detection of tissue CEA-like substance as an aid in the differential diagnosis of malignant mesothelioma. Pathology 1982;14:255-258